152 related articles for article (PubMed ID: 17420049)
21. Incidental early detection of a splenic marginal zone lymphoma by polymerase chain reaction analysis of paraffin-embedded tissue.
Dunphy CH; Bee C; McDonald JW; Grosso LE
Arch Pathol Lab Med; 1998 Jan; 122(1):84-6. PubMed ID: 9448023
[TBL] [Abstract][Full Text] [Related]
22. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
[TBL] [Abstract][Full Text] [Related]
23. Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.
Hockley SL; Morilla A; Else M; Dearden C; Catovsky D; Morgan GJ; Matutes E; Gonzalez D
Leukemia; 2010 May; 24(5):1084-6. PubMed ID: 20237507
[No Abstract] [Full Text] [Related]
24. Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.
Sol Mateo M; Mollejo M; Villuendas R; Algara P; Sánchez-Beato M; Martinez-Delgado B; Martínez P; Piris MA
Mol Pathol; 1998 Oct; 51(5):262-7. PubMed ID: 10193520
[TBL] [Abstract][Full Text] [Related]
25. Primary splenic marginal zone lymphoma with florid granulomatous reaction--a case report and review of literature.
Manipadam MT; Viswabandya A; Srivastava A
Pathol Res Pract; 2007; 203(4):239-43. PubMed ID: 17398014
[TBL] [Abstract][Full Text] [Related]
26. A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders.
Brisou G; Verney A; Wenner T; Baseggio L; Felman P; Callet-Bauchu E; Coiffier B; Berger F; Salles G; Traverse-Glehen A
Haematologica; 2014 Oct; 99(10):e197-8. PubMed ID: 24997147
[No Abstract] [Full Text] [Related]
27. CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphoma.
Franco V; Florena AM; Ascani S; Paulli M; Salvato M; Pileri SA
Histopathology; 2004 Apr; 44(4):381-6. PubMed ID: 15049905
[TBL] [Abstract][Full Text] [Related]
28. Unusual gamma heavy chain disease protein in a patient with splenic marginal-zone lymphoma.
Morita K; Kawamoto H; Takada H; Nakamura S; Ishii K; Okamoto Y
Ann Clin Biochem; 2006 Mar; 43(Pt 2):161-4. PubMed ID: 16536920
[TBL] [Abstract][Full Text] [Related]
29. Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.
Peveling-Oberhag J; Wolters F; Döring C; Walter D; Sellmann L; Scholtysik R; Lucioni M; Schubach M; Paulli M; Biskup S; Zeuzem S; Küppers R; Hansmann ML
BMC Cancer; 2015 Oct; 15():773. PubMed ID: 26498442
[TBL] [Abstract][Full Text] [Related]
30. IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.
Granai M; Amato T; Di Napoli A; Santi R; Vergoni F; Di Stefano G; Mancini V; Kovalchuk S; Cencini E; Carta AG; Aversa S; Ziepert M; Cevenini G; Lazzi S; Leoncini L; Bellan C
Virchows Arch; 2020 Jul; 477(1):143-150. PubMed ID: 31802229
[TBL] [Abstract][Full Text] [Related]
31. Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.
Traverse-Glehen A; Bachy E; Baseggio L; Callet-Bauchu E; Gazzo S; Verney A; Hayette S; Jallades L; Ffrench M; Salles G; Coiffier B; Felman P; Berger F
Histopathology; 2013 May; 62(6):876-93. PubMed ID: 23611359
[TBL] [Abstract][Full Text] [Related]
32. Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones.
Lefebvre C; Fabre B; Vettier C; Rabin L; Florin A; Wang J; Gressin R; Jacob MC; Callanan M; Leroux D
Hum Pathol; 2007 Apr; 38(4):660-7. PubMed ID: 17134739
[TBL] [Abstract][Full Text] [Related]
33. Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity.
Warsame AA; Aasheim HC; Nustad K; Trøen G; Tierens A; Wang V; Randen U; Dong HP; Heim S; Brech A; Delabie J
Blood; 2011 Sep; 118(12):3331-9. PubMed ID: 21725051
[TBL] [Abstract][Full Text] [Related]
34. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
[TBL] [Abstract][Full Text] [Related]
35. Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.
Zibellini S; Capello D; Forconi F; Marcatili P; Rossi D; Rattotti S; Franceschetti S; Sozzi E; Cencini E; Marasca R; Baldini L; Tucci A; Bertoni F; Passamonti F; Orlandi E; Varettoni M; Merli M; Rizzi S; Gattei V; Tramontano A; Paulli M; Gaidano G; Arcaini L
Haematologica; 2010 Oct; 95(10):1792-6. PubMed ID: 20511668
[TBL] [Abstract][Full Text] [Related]
36. A model for the development of human IgD-only B cells: Genotypic analyses suggest their generation in superantigen driven immune responses.
Seifert M; Steimle-Grauer SA; Goossens T; Hansmann ML; Bräuninger A; Küppers R
Mol Immunol; 2009 Feb; 46(4):630-9. PubMed ID: 18952293
[TBL] [Abstract][Full Text] [Related]
37. Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations.
Xochelli A; Bikos V; Polychronidou E; Galigalidou C; Agathangelidis A; Charlotte F; Moschonas P; Davis Z; Colombo M; Roumelioti M; Sutton LA; Groenen P; van den Brand M; Boudjoghra M; Algara P; Traverse-Glehen A; Ferrer A; Stalika E; Karypidou M; Kanellis G; Kalpadakis C; Mollejo M; Pangalis G; Vlamos P; Amini RM; Pospisilova S; Gonzalez D; Ponzoni M; Anagnostopoulos A; Giudicelli V; Lefranc MP; Espinet B; Panagiotidis P; Piris MA; Du MQ; Rosenquist R; Papadaki T; Belessi C; Ferrarini M; Oscier D; Tzovaras D; Ghia P; Davi F; Hadzidimitriou A; Stamatopoulos K
J Pathol; 2019 Apr; 247(4):416-421. PubMed ID: 30484876
[TBL] [Abstract][Full Text] [Related]
38. [Progress on Treatment of Splenic Marginal Zone Lymphoma-Review].
Wu L; Tian C; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):600-603. PubMed ID: 28446319
[TBL] [Abstract][Full Text] [Related]
39. Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire.
Bikos V; Stalika E; Baliakas P; Darzentas N; Davis Z; Traverse-Glehen A; Dagklis A; Kanellis G; Anagnostopoulos A; Tsaftaris A; Ponzoni M; Berger F; Felman P; Ghia P; Papadaki T; Oscier D; Belessi C; Stamatopoulos K
Leukemia; 2012 Dec; 26(12):2567-9. PubMed ID: 22858907
[No Abstract] [Full Text] [Related]
40. Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns.
Hockley SL; Giannouli S; Morilla A; Wotherspoon A; Morgan GJ; Matutes E; Gonzalez D
Br J Haematol; 2010 Feb; 148(4):666-9. PubMed ID: 19863540
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
